Cost effectiveness of the cancer prevention program for carriers of the BRCA1/2 mutation

Cost effectiveness of the cancer prevention program for carriers of the BRCA1/2 mutation

ABSTRACT OBJECTIVE: To analyze the cost effectiveness of the diagnostic program for the germline mutation in BRCA1/2 genes and of preventative strategies for the relatives of patients diagnosed with ovarian cancer associated with this mutation. METHODS: The study analyzed the cost effectiveness by...

Full description

Bibliographic Details
Main Authors:	Marcelo Cristiano de Azevedo Ramos, Maria Aparecida Azevedo Koike Folgueira, Simone Maistro, Alessandro Gonçalves Campolina, Patricia Coelho de Soárez, Geertruida Hendrika de Bock, Hillegonda Maria Dutilh Novaes, Maria Del Pilar Estevez Diz
Format:	Article
Language:	English
Published:	Universidade de São Paulo 2018-11-01
Series:	Revista de Saúde Pública
Subjects:	Ovarian Neoplasms, diagnosis Genes, BRCA1 Genes, BRCA2 Early Detection of Cancer, economics Cost-Effectiveness Evaluation
Online Access:	http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0034-89102018000100281&lng=en&tlng=en

Similar Items

Risk of metastasis in BRCA2 carriers diagnosed with triple‐negative breast cancer
by: Marcelo Moreno, et al.
Published: (2023-08-01)

How G4 ligands enhance the innate immune response in BRCA1/2- deficient cells and tumours
by: De Visser, Y, et al.
Published: (2020)

Predicting the Pathogenic Potential of BRCA1 and BRCA2 Gene Variants Identified in Clinical Genetic Testing
by: Clare Brookes, et al.
Published: (2015-05-01)

Predicting the Pathogenic Potential of BRCA1 and BRCA2 Gene Variants Identified in Clinical Genetic Testing
by: Clare Brookes, et al.
Published: (2015-05-01)

BRCA1/2 Variants and Metabolic Factors: Results From a Cohort of Italian Female Carriers
by: Andreina Oliverio, et al.
Published: (2020-11-01)

Evaluation of the indication of BRCA1/2 genetic tests in Iranian women and acceptance rate of risk‐reducing surgeries in BRCA mutation carriers
by: Mahtab Vasigh, et al.
Published: (2022-02-01)

Prostate screening uptake in Australian <it>BRCA1 </it>and <it>BRCA2 </it>carriers
by: McKinley Joanne M, et al.
Published: (2007-09-01)

MANAGEMENT OF BREAST CANCER WITH BRCA GENE MUTATION
by: I Wayan Ari Sumardika, et al.
Published: (2013-09-01)

Analysis of polymorphisms in BRCA1 and BRCA2 genes in a population sample of canines from Uruguay
by: Alicia Decuadro, et al.
Published: (2022-08-01)

Genetic Variation of The BRCA1 and BRCA2 Genes in Macedonian Patients
by: Plaseska-Karanfilska Dijana, et al.
Published: (2012-12-01)

BRCA1 and BRCA2 genes mutations among women with clinical signs of hereditary breast cancer in western Belarus
by: Alena Savanevich, et al.
Published: (2021-07-01)

Clinical follow up of Mexican women with early onset of breast cancer and mutations in the BRCA1 and BRCA2 genes Estudio de seguimiento clínico de mujeres mexicanas con cáncer de mama de inicio temprano y mutaciones en los genes BRCA1 y BRCA2
by: Ana Laura Calderón-Garcidueñas, et al.
Published: (2005-04-01)

Risk-Reducing Options for High-Grade Serous Gynecologic Malignancy in BRCA1/2
by: Lauren Clarfield, et al.
Published: (2022-03-01)

Analysis of BRCA1 and BRCA2 mutations in Brazilian breast cancer patients with positive family history
by: Rozany Mucha Dufloth, et al.

Clinicopathological Characteristics of Patients with BRCA Mutation Breast Cancer in North Sumatera: Case Report
by: Dedy Hermansyah, et al.
Published: (2023-04-01)

Diagnostic Screening Workflow for Mutations in the BRCA1 and BRCA2 Genes
by: Stella Lai, et al.
Published: (2015-01-01)

Prevalance of <it>BRCA1</it> and <it>BRCA2</it> mutations in familial breast cancer patients in Lebanon
by: Jalkh Nadine, et al.
Published: (2012-06-01)

Age of natural menopause onset in BRCA1/2 carriers – systematic review and meta-analysis
by: Łukasz Kępczyński, et al.
Published: (2021-01-01)

Dermatological and Dermoscopic Baselines in BRCA Mutation Carriers
by: Giovanni Paolino, et al.
Published: (2022-04-01)

Surgical and Systemic Treatment of Hereditary Breast Cancer: A Mini-Review With a Focus on BRCA1 and BRCA2 Mutations
by: Athanasios Pouptsis, et al.
Published: (2020-10-01)

Survival Benefit of Germline BRCA Mutation is Associated with Residual Disease in Ovarian Cancer
by: Tingyan Shi, et al.
Published: (2018-07-01)

Analysis of 5382insC (BRCA1) and 6174delT (BRCA2) mutations in 382 healthy Chilean women with a family history of breast cancer
by: LILIAN JARA, et al.
Published: (2002-01-01)

Genetics of breast cancer: Contribution of BRCA1/2 genes alterations to hereditary predisposition
by: Branković-Magić Mirjana, et al.
Published: (2012-01-01)

Características clínicas de pacientes con Cáncer de Mama y / o Cáncer de Ovario con mutaciones en los genes BRCA1 y BRCA2 en Córdoba, Argentina
by: Claudia Alejandra Martin, et al.
Published: (2022-09-01)

Efficacy and safety of treatment regimens for patients with metastatic, locally advanced, or recurrent breast cancer carrying BRCA1/BRCA2 pathogenic variants: A network meta-analysis
by: Yingxuan Zhu, et al.
Published: (2023-02-01)

Can harmful lifestyle, obesity and weight changes increase the risk of breast cancer in BRCA 1 and BRCA 2 mutation carriers? A Mini review
by: A. Daniele, et al.
Published: (2021-10-01)

COVID-19 vaccination uptake and safety profile among germline BRCA1 and BRCA2 pathogenic variant carriers in Singapore
by: Zewen Zhang, et al.
Published: (2023-04-01)

Correlation between the number of false positive variants and the quality of results using Ion Torrent PGM™ sequencing to screen BRCA genes
by: Tiago César Gouvêa Moreira, et al.
Published: (2021-12-01)

Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review
by: Lisa Krassuski, et al.
Published: (2019-08-01)

Analysis of the pathogenic variants of BRCA1 and BRCA2 using next-generation sequencing in women with familial breast cancer: a case–control study
by: Omar Alejandro Zayas-Villanueva, et al.
Published: (2019-07-01)

Exome Sequencing in BRCA1-2 Candidate Familias: The Contribution of Other Cancer Susceptibility Genes
by: Gabriella Doddato, et al.
Published: (2021-05-01)

Genetic variants of prospectively demonstrated phenocopies in BRCA1/2 kindreds
by: Mev Dominguez-Valentin, et al.
Published: (2018-01-01)

A contribuição dos genes BRCA na predisposição hereditária ao câncer de mama
by: Luis Cláudio Belo Amendola, et al.
Published: (2005-12-01)

The ectopic expression of BRCA1 is associated with genesis, progression, and prognosis of breast cancer in young patients
by: Zhang Qingli, et al.
Published: (2012-12-01)

Corrigendum: Exome Sequencing in BRCA1-2 Candidate Familias: The Contribution of Other Cancer Susceptibility Genes
by: Gabriella Doddato, et al.
Published: (2021-08-01)

BRCA Testing in Serbia and Montenegro
by: Brankovic-Magic Mirjana
Published: (2006-10-01)

Prostate Cancer: Germline Mutations in BRCA1 and BRCA2
by: Pankaja Umarane, et al.
Published: (2023-03-01)

A Dietary Intervention to Lower Serum Levels of IGF-I in BRCA Mutation Carriers
by: Patrizia Pasanisi, et al.
Published: (2018-09-01)

Investigating the role of BRCA2 in the maintenance of chromosomal stability
by: Rampazzo, L
Published: (2021)

Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study
by: Delal Akdeniz, et al.
Published: (2022-02-01)